Home Healthcare Biotechnology Non-Invasive Liquid Biopsy Market

Non-Invasive Liquid Biopsy Market Size, Share & Trends Analysis Report By Offering (Product, Services), By Sample (Stool, Urine, Saliva, Others), By Technology (Polymerase Chain Reaction, Sequencing, Microarray, Others), By Applications (Oncology, Reproductive Health, Metabolic Disorders, Others), By End-Users (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR4330DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Non-Invasive Liquid Biopsy Market, By Offering 2022-2034 (USD MILLION/ Units)
    1. Product
    2. Services
  2. Non-Invasive Liquid Biopsy Market, By Sample 2022-2034 (USD MILLION/ Units)
    1. Stool
    2. Urine
    3. Saliva
    4. Others
  3. Non-Invasive Liquid Biopsy Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Polymerase Chain Reaction
    2. Sequencing
    3. Microarray
    4. Others
  4. Non-Invasive Liquid Biopsy Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Reproductive Health
    3. Metabolic Disorders
    4. Others
  5. Non-Invasive Liquid Biopsy Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Diagnostic Laboratories
    2. Academic and Research Institutions
    3. Others
  6. Regional Non-Invasive Liquid Biopsy Market
    1. North America
      1. North America Non-Invasive Liquid Biopsy Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Services
      2. North America Non-Invasive Liquid Biopsy Market By Sample 2022-2034 (USD MILLION/ Units)
        1. Stool
        2. Urine
        3. Saliva
        4. Others
      3. North America Non-Invasive Liquid Biopsy Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction
        2. Sequencing
        3. Microarray
        4. Others
      4. North America Non-Invasive Liquid Biopsy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Reproductive Health
        3. Metabolic Disorders
        4. Others
      5. North America Non-Invasive Liquid Biopsy Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Laboratories
        2. Academic and Research Institutions
        3. Others
      6. U.S.
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      7. Canada
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
    2. Europe
      1. Europe Non-Invasive Liquid Biopsy Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Services
      2. Europe Non-Invasive Liquid Biopsy Market By Sample 2022-2034 (USD MILLION/ Units)
        1. Stool
        2. Urine
        3. Saliva
        4. Others
      3. Europe Non-Invasive Liquid Biopsy Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction
        2. Sequencing
        3. Microarray
        4. Others
      4. Europe Non-Invasive Liquid Biopsy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Reproductive Health
        3. Metabolic Disorders
        4. Others
      5. Europe Non-Invasive Liquid Biopsy Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Laboratories
        2. Academic and Research Institutions
        3. Others
      6. U.K.
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      7. Germany
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      8. France
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      9. Spain
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      10. Italy
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      11. Russia
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      12. Nordic
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      13. Benelux
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      14. Rest of Europe
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
    3. APAC
      1. APAC Non-Invasive Liquid Biopsy Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Services
      2. APAC Non-Invasive Liquid Biopsy Market By Sample 2022-2034 (USD MILLION/ Units)
        1. Stool
        2. Urine
        3. Saliva
        4. Others
      3. APAC Non-Invasive Liquid Biopsy Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction
        2. Sequencing
        3. Microarray
        4. Others
      4. APAC Non-Invasive Liquid Biopsy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Reproductive Health
        3. Metabolic Disorders
        4. Others
      5. APAC Non-Invasive Liquid Biopsy Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Laboratories
        2. Academic and Research Institutions
        3. Others
      6. China
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      7. Korea
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      8. Japan
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      9. India
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      10. Australia
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      11. Taiwan
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      12. South East Asia
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      13. Rest of Asia-Pacific
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
    4. Middle East and Africa
      1. Middle East and Africa Non-Invasive Liquid Biopsy Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Services
      2. Middle East and Africa Non-Invasive Liquid Biopsy Market By Sample 2022-2034 (USD MILLION/ Units)
        1. Stool
        2. Urine
        3. Saliva
        4. Others
      3. Middle East and Africa Non-Invasive Liquid Biopsy Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction
        2. Sequencing
        3. Microarray
        4. Others
      4. Middle East and Africa Non-Invasive Liquid Biopsy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Reproductive Health
        3. Metabolic Disorders
        4. Others
      5. Middle East and Africa Non-Invasive Liquid Biopsy Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Laboratories
        2. Academic and Research Institutions
        3. Others
      6. UAE
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      7. Turkey
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      8. Saudi Arabia
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      9. South Africa
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      10. Egypt
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      11. Nigeria
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      12. Rest of MEA
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
    5. LATAM
      1. LATAM Non-Invasive Liquid Biopsy Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Services
      2. LATAM Non-Invasive Liquid Biopsy Market By Sample 2022-2034 (USD MILLION/ Units)
        1. Stool
        2. Urine
        3. Saliva
        4. Others
      3. LATAM Non-Invasive Liquid Biopsy Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction
        2. Sequencing
        3. Microarray
        4. Others
      4. LATAM Non-Invasive Liquid Biopsy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Reproductive Health
        3. Metabolic Disorders
        4. Others
      5. LATAM Non-Invasive Liquid Biopsy Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Laboratories
        2. Academic and Research Institutions
        3. Others
      6. Brazil
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      7. Mexico
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      8. Argentina
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      9. Chile
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      10. Colombia
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
      11. Rest of LATAM
        1. Product
        2. Services
        3. Stool
        4. Urine
        5. Saliva
        6. Others
        7. Polymerase Chain Reaction
        8. Sequencing
        9. Microarray
        10. Others
        11. Oncology
        12. Reproductive Health
        13. Metabolic Disorders
        14. Others
        15. Hospitals and Diagnostic Laboratories
        16. Academic and Research Institutions
        17. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.